Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating benjakul extract in combination with loratadine for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benjakul Extract
  • Loratadine (Loratadine)

Snippet

Sponsor: Thammasat University | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED